Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
Academic rigour, journalistic flair
Articles on Chemotherapy
Displaying 41 - 60 of 78 articles
The majority of research suggests the benefits of mammography screening greatly outweigh the harms for women over age 40.
October is breast cancer awareness month. Women should know there is no reliable evidence that routine mammograms reduce death from breast cancer, and there’s good evidence that they cause harm.
A twinge can be all it takes to convince patients they have a new tumour
Chemotherapy is the use of drugs to treat cancer. It is often paired with surgery, radiotherapy and immunotherapy in a cancer treatment plan.
Tumour evolution was first identified 40 years ago. We’re finally making good progress with it.
Nanoparticles are a form of transport for drugs and can go places drugs wouldn’t be able to go on their own. They make drug delivery more targeted, reducing collateral damage to healthy tissues.
The incidence of Hodgkin’s lymphoma in Kenya isn’t known, but new information is emerging to shed light on its prevalence.
The chances of surviving breast cancer are improving everyday due to advanced research and new treatment techniques.
NSW is about to embark on the largest and most definitive clinical trial ever of medicinal cannabis for chemotherapy-induced nausea and vomiting.
In Australia, there is no system in place to support people returning to work after cancer treatment – or to provide advice to their employers on how to help them.
Children’s cancer is a rare disease, which means the market is small and pharmaceutical companies have few incentives to develop drugs for these cancers.
Research in animals and humans shows periods of fasting before and after chemotherapy protects healthy cells while killing cancerous ones more efficiently.
Humble hydrogels could one day replace hypodermic needles and repair damaged hearts.
New tools help doctors and breast cancer patients decide whether chemotherapy is needed. A recent study suggested that many can forgo chemo. But the decision is complicated. Here’s why.
One in ten cancer patients will face fertility issues after treatment, but less than 50% are given options to preserve fertility. And those who are offered options can face significant cost barriers.
Humans can more easily tolerate tumours in large or paired organs than in small, critical ones. This could be why the latter have evolved more cancer-fighting mechanisms.
There is actually no existing evidence to show that a flat dose of 100mg of carboplatin provides inferior outcomes.
Glioblastoma is an aggressive form of brain cancer that has a very poor prognosis. Despite the current best therapies half its sufferers survive for 15 months and less than 5% are alive after 5 years.
We found one third of patients near the end of their life received non-beneficial treatments in hospitals around the world. These included initiating chemotherapy and providing emergency surgery.
Top contributors
-
Professor and Director Academic Excellence, Macquarie University
-
Research Fellow, ZERO2FIVE Food Industry Centre, Cardiff Metropolitan University
-
Associate Professor (conjoint), Children's Cancer Institute
-
Professor of Sociology, Ball State University
-
Adjunct Professsor, School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Clinical Instructor, Vanderbilt University
-
Lecturer in Pharmacy, University of Sydney
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
Senior Coordinator, Communications and Events, Monash University
-
Professor, Internal Medicine, University of Michigan
-
Associate Professor of Applied Mathematics, University of Waterloo
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Associate Professor of Behavioral Sciences, University of South Carolina
-
Associate Professor, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Associate Professor of Medicine, Sydney Medical School, Concord Clinical School; Medical Oncologist, Concord Cancer Centre, University of Sydney
